Treatment of chronic hemodialysis patients with low-dose fenofibrate effectively reduces plasma lipids and affects plasma redox status

Overview of attention for article published in Lipids in Health and Disease, May 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 tweeters

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 40 Mendeley

Summary Twitter Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study

Article in Frontiers in Cardiovascular Medicine (November 2022)

Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV Study

Article in Clinical Therapeutics (September 2021)

Association of apoE gene polymorphisms with lipid metabolism in renal diseases

Article in African Health Sciences (September 2020)